Malignancy of the prostate Prostate Cancer
Conditions
Interventions
None listed
Sponsors
Vrije Universiteit Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Men * 45 years with no history of PCa and no prior prostate biopsies with suspected, potentially aggressive PCa due to an elevated PSA-level between 20 and 50 ng/mL are eligible.
Exclusion criteria
Exclusion criteria: - Previous diagnosis of prostate cancer - Previous prostate biopsy - Previous PSMA PET/CT scan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OUTCOME MEASURES. It is assessed: 1) the (reduced) number of prostate biopsy procedures in the 18F-PSMA-diagnostic pathway, 2) the (reduced) number of prostate biopsy cores taken, 3) the (increased) number of clinically significant (Gleason score 3 + 4 = 7, 4 + 3 = 7,8-10) prostate cancers detected per prostate biopsy session, 4) the calculated (reduced) number of complicated urinary tract infections such as urosepsis due to prostate biopsy. | — |
Secondary
| Measure | Time frame |
|---|---|
| ND | — |
Countries
Netherlands
Outcome results
None listed